{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T15:40:04Z","timestamp":1778254804384,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,20]]},"DOI":"10.7759\/cureus.101955","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:29:38Z","timestamp":1768980578000},"source":"Crossref","is-referenced-by-count":1,"title":["Relationship Between Elevated Plasma Homocysteine Levels and Severity of Peripheral Neuropathy in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Analysis"],"prefix":"10.7759","author":[{"given":"Muhammad","family":"Toqeer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masood Uz Zaman","family":"Babar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiza","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumaila","family":"Israr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eman","family":"Masood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farooq Ahmad","family":"Malik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunaira","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul Ahad","family":"Mehboob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1089\/pop.2015.0181","article-title":"Diabetes 2030: insights from yesterday, today, and future trends","volume":"20","author":"Rowley WR","year":"2017","unstructured":"Rowley WR, Bezold C, Arikan Y, Byrne E, Krohe S. Diabetes 2030: insights from yesterday, today, and future trends. Popul Health Manag. 2017, 20:6-12. 10.1089\/pop.2015.0181","journal-title":"Popul Health Manag"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003882","article-title":"Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review","volume":"88","author":"Waldfogel JM","year":"2017","unstructured":"Waldfogel JM, Nesbit SA, Dy SM, et al.. Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review. Neurology. 2017, 88:1958-67. 10.1212\/WNL.0000000000003882","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui R","year":"2017","unstructured":"Pop-Busui R, Boulton AJ, Feldman EL, et al.. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care. 2017, 40:136-54. 10.2337\/dc16-2042","journal-title":"Diabetes Care"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic microvascular disease: an Endocrine Society scientific statement","volume":"102","author":"Barrett EJ","year":"2017","unstructured":"Barrett EJ, Liu Z, Khamaisi M, et al.. Diabetic microvascular disease: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2017, 102:4343-410. 10.1210\/jc.2017-01922","journal-title":"J Clin Endocrinol Metab"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2017.02.005","article-title":"New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain","volume":"93","author":"Feldman EL","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS, Bennett DL. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017, 93:1296-313. 10.1016\/j.neuron.2017.02.005","journal-title":"Neuron"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s12038-015-9523-7","article-title":"Oxidation as an important factor of protein damage: implications for Maillard reaction","volume":"40","author":"Trnkova L","year":"2015","unstructured":"Trnkova L, Drsata J, Bousova I. Oxidation as an important factor of protein damage: implications for Maillard reaction. J Biosci. 2015, 40:419-39. 10.1007\/s12038-015-9523-7","journal-title":"J Biosci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302535","article-title":"The role of uric acid in the pathogenesis of human cardiovascular disease","volume":"99","author":"Kanbay M","year":"2013","unstructured":"Kanbay M, Segal M, Afsar B, Kang DH, Rodriguez-Iturbe B, Johnson RJ. The role of uric acid in the pathogenesis of human cardiovascular disease. Heart. 2013, 99:759-66. 10.1136\/heartjnl-2012-302535","journal-title":"Heart"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2012.01.013","article-title":"Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications","volume":"59","author":"Puddu P","year":"2012","unstructured":"Puddu P, Puddu GM, Cravero E, Vizioli L, Muscari A. Relationships among hyperuricemia, endothelial dysfunction and cardiovascular disease: molecular mechanisms and clinical implications. J Cardiol. 2012, 59:235-42. 10.1016\/j.jjcc.2012.01.013","journal-title":"J Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey AS","year":"2009","unstructured":"Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009, 150:604-12. 10.7326\/0003-4819-150-9-200905050-00006","journal-title":"Ann Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.10.4.432","article-title":"Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy","volume":"10","author":"Dyck PJ","year":"1987","unstructured":"Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, Service FJ. Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diabetes Care. 1987, 10:432-40. 10.2337\/diacare.10.4.432","journal-title":"Diabetes Care"},{"key":"ref11","unstructured":"Patient Version. Michigan Neuropathy Screening Instrument. Accessed: January 15, 2021: https:\/\/medresearch.umich.edu\/sites\/default\/files\/2025-07\/MNSI_patient.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64032-1.00014-X","article-title":"Nerve conduction studies: basic concepts","volume":"160","author":"Tavee J","year":"2019","unstructured":"Tavee J. Nerve conduction studies: basic concepts. Handb Clin Neurol. 2019, 160:217-24. 10.1016\/B978-0-444-64032-1.00014-X","journal-title":"Handb Clin Neurol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/21548331.2019.1549916","article-title":"The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study","volume":"47","author":"Kaewput W","year":"2019","unstructured":"Kaewput W, Thongprayoon C, Rangsin R, Mao MA, Satirapoj B, Cheungpasitporn W. The association between renal function and neurological diseases in type 2 diabetes: a multicenter nationwide cross-sectional study. Hosp Pract (1995). 2019, 47:46-52. 10.1080\/21548331.2019.1549916","journal-title":"Hosp Pract (1995)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2228","article-title":"The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes","volume":"29","author":"Davies M","year":"2006","unstructured":"Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006, 29:1518-22. 10.2337\/dc05-2228","journal-title":"Diabetes Care"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott CA","year":"2011","unstructured":"Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011, 34:2220-4. 10.2337\/dc11-1108","journal-title":"Diabetes Care"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye S","year":"2005","unstructured":"Tesfaye S, Chaturvedi N, Eaton SE, et al.. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005, 352:341-50. 10.1056\/NEJMoa032782","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/j.2040-1124.2010.00070.x","article-title":"Mechanism of diabetic neuropathy: Where are we now and where to go?","volume":"2","author":"Yagihashi S","year":"2011","unstructured":"Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go?. J Diabetes Investig. 2011, 2:18-32. 10.1111\/j.2040-1124.2010.00070.x","journal-title":"J Diabetes Investig"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin YY","year":"2008","unstructured":"Sautin YY, Johnson RJ. Uric acid: the oxidant-antioxidant paradox. Nucleosides Nucleotides Nucleic Acids. 2008, 27:608-19. 10.1080\/15257770802138558","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000069700.62727.C5","article-title":"Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?","volume":"41","author":"Johnson RJ","year":"2003","unstructured":"Johnson RJ, Kang DH, Feig D, et al.. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension. 2003, 41:1183-90. 10.1161\/01.HYP.0000069700.62727.C5","journal-title":"Hypertension"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/428227-relationship-between-elevated-plasma-homocysteine-levels-and-severity-of-peripheral-neuropathy-in-patients-with-type-2-diabetes-mellitus-a-cross-sectional-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T07:29:39Z","timestamp":1768980579000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/428227-relationship-between-elevated-plasma-homocysteine-levels-and-severity-of-peripheral-neuropathy-in-patients-with-type-2-diabetes-mellitus-a-cross-sectional-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.101955","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,20]]}}}